EPLAW PATENT BLOG

News – Book: A Practitioner’s Guide to the Unified Patent Court and Unitary Patent

Posted: May 24th, 2022

The book: “A Practitioner’s Guide to the Unified Patent Court and Unitary Patent” , authored by Paul England is scheduled to be published by Bloomsbury in November 2022 From the blurb: “A Practitioner’s Guide to the Unified Patent Court and Unitary Patent provides practical and detailed advice on all aspects of the system for those […]

READ MORE

NL – Bristol-Myers Squibb v. Sandoz / Apaxiban

Posted: May 19th, 2022

Bristol-Myers Squibb Holdings Ireland Unlimited Company v. Sandoz B.V., District Court The Hague (interlocutory decision), 10 May 2022, Case no.  ECLI:NL:RBDHA:2022:4385 BMS markets the medicine Eliquis®, with apixaban as the active ingredient. Apixaban is a substance that inhibits the action of factor Xa. Inhibiting factor Xa helps prevent blood clots from forming. Eliquis® is used […]

READ MORE

IT – Novartis Pharma v. Medac Farma

Posted: May 5th, 2022

Novartis Pharma vs. Medac Farma, Court of Milan, 10 January 2022, Case number 11933/2022 A decision on second medical use patent and skinny labelling in Italy was handed down by the Court of Milan on 10 January 2022. The Court held skinny label alone as insufficient to avoid infringement of second medical use claims and […]

READ MORE

CJEU – Phoenix v. Harting

Posted: April 29th, 2022

Preliminary ruling under Article 267 TFEU in the case between Phoenix Contact GmbH & Co. KG v. HARTING Deutschland GmbH & Co. KG, Harting Electric GmbH & Co. KG, 28 April 2022, Case No. C‑44/21, ECLI:EU:C:2022:309 “By its question, the referring court asks, in essence, whether Article 9(1) of Directive 2004/48 must be interpreted as […]

READ MORE

EPLAW – YOUNG EPLAW 2022 Annual Congress

Posted: April 26th, 2022

After a three year covid-related hiatus, the Young EPLAW event finally took place in person again in Brussels yesterday. The event was preceded by a mock trial and a social event on Sunday. The program was busy and varied, with topics ranging from ‘Hot topics in FRAND litigation’ to ‘Confidentiality in court proceedings’ ,  ‘Cross […]

READ MORE

NL – Novartis v. Mylan

Posted: April 20th, 2022

Novartis versus Mylan, PI judge District Court of The Hague 22 March 2022, ECLI:NL:RBDHA:2022:2490 (interlocutory decision) Market entry by the generic pharmaceutical company Mylan before the grant of a Novartis patent – which will be infringed once granted – is not unlawful. Not even if Novartis’ patent will be granted with certainty and the wording […]

READ MORE

ES – SHARK HELMETS v. TECH DESIGN TEAM

Posted: April 13th, 2022

Shark Helmets S.A.S. v. Tech Design Team S.L., Commercial Court no. 5 of Barcelona, 28 October 2021, Docket No. 729/2020 In this decision issued on 28 October 2021, Barcelona first instance Patent Courts examined the question of interpreting the extent of protection of the claims in view of the patent description and drawings. The plaintiff, […]

READ MORE

UK – Optis v. Apple

Posted: March 30th, 2022

Judgment handed down in the last of the technical trials in Optis v Apple saga: Optis succeeds in arguing that its patents are valid and infringed by Apple Overview The 15 March 2022 judgment of Mr Justice Meade is the latest in the Optis v Apple saga. It is the last in the series of […]

READ MORE

News – 2022 LES International Annual Conference

Posted: March 29th, 2022

The 2022 LES International Annual Conference will take place in Venezia (Italy) from 8 to 10 May 2022 EPLAW members are welcome to attend the conference, entitled: “Back to Licensing: Restarting Business and Fueling Innovation” The conference website provides information on the program & registrations: www.lesi2022.org. More information can also be found here (The letter […]

READ MORE

ES – Vorwerk v. Lidl Supermercados

Posted: March 29th, 2022

Vorwerk v. Lidl Supermercados, Court of Appeals of Barcelona, Spain, 13 January 2022, Appeal Docket No. 880/2021 (ECLI:ES:APB:2022:1) One year after the first-instance ruling in one of the most mediatic patent cases in Spain, the Court of Appeals of Barcelona rendered a judgment changing course, namely inreversing the first instance judgment and declaring the invalidity […]

READ MORE